Tyra Biosciences (TYRA) Competitors $16.39 -0.29 (-1.74%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TYRA vs. APLS, HCM, APGE, XENE, PTCT, EWTX, IOVA, ZLAB, RYTM, and MLTXShould you be buying Tyra Biosciences stock or one of its competitors? The main competitors of Tyra Biosciences include Apellis Pharmaceuticals (APLS), HUTCHMED (HCM), Apogee Therapeutics (APGE), Xenon Pharmaceuticals (XENE), PTC Therapeutics (PTCT), Edgewise Therapeutics (EWTX), Iovance Biotherapeutics (IOVA), Zai Lab (ZLAB), Rhythm Pharmaceuticals (RYTM), and MoonLake Immunotherapeutics (MLTX). These companies are all part of the "pharmaceutical products" industry. Tyra Biosciences vs. Apellis Pharmaceuticals HUTCHMED Apogee Therapeutics Xenon Pharmaceuticals PTC Therapeutics Edgewise Therapeutics Iovance Biotherapeutics Zai Lab Rhythm Pharmaceuticals MoonLake Immunotherapeutics Tyra Biosciences (NASDAQ:TYRA) and Apellis Pharmaceuticals (NASDAQ:APLS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability. Do institutionals and insiders hold more shares of TYRA or APLS? 84.1% of Tyra Biosciences shares are owned by institutional investors. Comparatively, 96.3% of Apellis Pharmaceuticals shares are owned by institutional investors. 15.4% of Tyra Biosciences shares are owned by insiders. Comparatively, 6.8% of Apellis Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, TYRA or APLS? Tyra Biosciences has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, Apellis Pharmaceuticals has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Do analysts prefer TYRA or APLS? Tyra Biosciences presently has a consensus price target of $31.40, suggesting a potential upside of 91.58%. Apellis Pharmaceuticals has a consensus price target of $65.41, suggesting a potential upside of 133.78%. Given Apellis Pharmaceuticals' higher possible upside, analysts plainly believe Apellis Pharmaceuticals is more favorable than Tyra Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Apellis Pharmaceuticals 0 Sell rating(s) 5 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 2.84 Is TYRA or APLS more profitable? Tyra Biosciences has a net margin of 0.00% compared to Apellis Pharmaceuticals' net margin of -52.99%. Tyra Biosciences' return on equity of -27.13% beat Apellis Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Tyra BiosciencesN/A -27.13% -25.65% Apellis Pharmaceuticals -52.99%-138.32%-39.63% Does the media prefer TYRA or APLS? In the previous week, Apellis Pharmaceuticals had 8 more articles in the media than Tyra Biosciences. MarketBeat recorded 23 mentions for Apellis Pharmaceuticals and 15 mentions for Tyra Biosciences. Apellis Pharmaceuticals' average media sentiment score of 0.58 beat Tyra Biosciences' score of 0.42 indicating that Apellis Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tyra Biosciences 4 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Apellis Pharmaceuticals 4 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor TYRA or APLS? Apellis Pharmaceuticals received 306 more outperform votes than Tyra Biosciences when rated by MarketBeat users. However, 73.17% of users gave Tyra Biosciences an outperform vote while only 67.74% of users gave Apellis Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTyra BiosciencesOutperform Votes3073.17% Underperform Votes1126.83% Apellis PharmaceuticalsOutperform Votes33667.74% Underperform Votes16032.26% Which has stronger valuation and earnings, TYRA or APLS? Tyra Biosciences has higher earnings, but lower revenue than Apellis Pharmaceuticals. Apellis Pharmaceuticals is trading at a lower price-to-earnings ratio than Tyra Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTyra BiosciencesN/AN/A-$69.13M-$1.69-9.70Apellis Pharmaceuticals$628.79M5.42-$528.63M-$2.74-10.21 SummaryTyra Biosciences beats Apellis Pharmaceuticals on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TYRA vs. The Competition Export to ExcelMetricTyra BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$865.56M$7.02B$5.39B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio-9.709.47113.8115.12Price / SalesN/A381.571,483.2593.03Price / CashN/A47.3339.6434.05Price / Book3.465.324.665.02Net Income-$69.13M$153.56M$119.06M$225.46M7 Day Performance-25.26%0.12%0.79%0.37%1 Month Performance-26.76%15.23%5.65%3.57%1 Year Performance28.55%41.16%36.76%29.42% Tyra Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TYRATyra Biosciences3.7817 of 5 stars$16.39-1.7%$31.40+91.6%+38.1%$865.56MN/A-9.7020Upcoming EarningsInsider BuyingAPLSApellis Pharmaceuticals4.519 of 5 stars$27.71+1.1%$65.41+136.1%-43.9%$3.36B$628.79M-10.11702Upcoming EarningsAnalyst UpgradeAnalyst RevisionHCMHUTCHMED1.203 of 5 stars$18.95-3.3%$20.55+8.4%-4.5%$3.30B$420.26M0.001,988Short Interest ↑News CoverageGap DownAPGEApogee Therapeutics2.5858 of 5 stars$54.90-2.5%$78.50+43.0%+203.9%$3.21BN/A-26.5291XENEXenon Pharmaceuticals3.4405 of 5 stars$41.89+0.3%$57.45+37.2%+33.5%$3.16B$9.43M-15.29251Options VolumeNews CoveragePositive NewsPTCTPTC Therapeutics2.9842 of 5 stars$40.66-4.3%$40.08-1.4%+119.3%$3.13B$937.82M-6.441,410Upcoming EarningsEWTXEdgewise Therapeutics2.0142 of 5 stars$33.32-3.3%$35.60+6.8%+427.1%$3.12BN/A-21.5060Short Interest ↓Positive NewsIOVAIovance Biotherapeutics3.7643 of 5 stars$11.04+2.1%$22.33+102.3%+189.1%$3.09B$32.77M-6.61500Upcoming EarningsZLABZai Lab3.067 of 5 stars$30.84-1.9%$52.50+70.2%+23.1%$3.07B$322.71M-10.082,175Gap DownRYTMRhythm Pharmaceuticals3.3956 of 5 stars$49.54flat$60.33+21.8%+104.3%$3.02B$101.78M-11.36140Upcoming EarningsAnalyst ForecastMLTXMoonLake Immunotherapeutics1.6766 of 5 stars$47.00-2.5%$80.45+71.2%-3.7%$3.00BN/A-51.652News CoveragePositive News Related Companies and Tools Related Companies APLS Alternatives HCM Alternatives APGE Alternatives XENE Alternatives PTCT Alternatives EWTX Alternatives IOVA Alternatives ZLAB Alternatives RYTM Alternatives MLTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TYRA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
